Group items tagged

"ScienceDaily (Aug. 31, 2010) - Two new groundbreaking scientific papers by researchers at UC Santa Barbara demonstrate the synthesis of nanosize biological particles with the potential to fight cancer and other illnesses. The studies introduce new approaches that are considered "green" nanobiotechnology because they use no artificial compounds."

"The report  gets across one very basic message: in the eyes of the leading experts on aerospace technology worldwide: harvesting solar power in space and transmitting it to earth is no longer science fiction," says author Howard Bloom in a companion announcement by the Space Development Steering Committee. "It is sound, current-technology-based science fact.  And it is a green energy option we can't ignore.

One way to change something big is to get people really riled up about how you've changed something small. Repaint the boat, and let them to argue about that. By the time they've realized that green is no worse than blue, they won't have the energy to wonder whether it was a smart idea for you to set sail for Australia.

A 36-year-old man has received the world's first synthetic trachea, made from a synthetic scaffold seeded with his own stem cells, in an operation at the Karolinska University Hospital in Stockholm, Sweden. Professor Paolo Macchiarini of Karolinska University Hospital and Karolinska Institutet led an international team, including professor Alexander Seifalian from University College London, who designed and built the nanocomposite tracheal scaffold, and Harvard Bioscience, which produced a specifically designed bioreactor used to seed the scaffold with the patient´s own stem cells. The cells were grown on the scaffold inside the bioreactor for two days before transplantation to the patient. Because the cells used to regenerate the trachea were the patient's own, there has been no rejection of the transplant and the patient is not taking immunosuppressive drugs. "The big conceptual breakthrough is that we can move from transplanting organs to manufacturing them for patients," says David Green, the president of Harvard Bioscience in Holliston, Massachusetts. Transplantations of tissue-engineered windpipes with synthetic scaffolds in combination with the patient's own stem cells as a standard procedure means that patients will not have to wait for a suitable donor organ. Patients could benefit from earlier surgery and have a greater chance of cure. This would be of especially great value for children, since the availability of donor tracheas is much lower than for adult patients.